Enliven Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Enliven Therapeutics's balance sheet done over the years? Its assets were worth $271,867,000 last year, which is more than in the previous period. 10% of Enliven Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $25,961,000, which means an decrease by -84% compared compared to last year.

Debt to Assets

Enliven Therapeutics, Inc. (NASDAQ:ELVN): Debt to assets
2017 10223000 1.48M 14.54%
2018 7705000 34.02M 441.54%
2019 33298000 4.38M 13.16%
2020 131003000 151.30M 115.5%
2021 113329000 156.21M 137.84%
2022 83298000 160.12M 192.23%
2023 271867000 25.96M 9.55%

ELVN Balance Sheet (2017 โ€“ 2023)

2023 2022 2021 2020 2019 2018 2017
Assets
Current assets:
Cash and cash equivalents
100.14M75.53M110.02M130.36M4.93M7.38M9.67M
Short term investments
153.00M041.96M40.52M23.97M00
Net receivables
0000000
Inventory
0000000
Other current assets
13.00M2.21M646K222K1.71M323K552K
Total current assets
266.15M77.75M110.67M130.58M30.62M7.70M10.22M
Non-current assets:
Property, Plant and Equipment
1.06M1.51M954K416K442K00
Goodwill
0000000
Intangible assets
0000000
Long term investments
054K175K88K88K00
Other non-current assets
4.65M3.97M1.53M-88K2.14M00
Total non-current assets
5.71M5.54M2.65M416K2.67M00
Total assets
271.86M83.29M113.32M131.00M33.29M7.70M10.22M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
05.50M2.70M429K000
Short term debt
335K323K159K105K000
Total current liabilities
25.89M9.71M5.75M1.47M4.19M1.83M826K
Non-current liabilities:
Long term debt
02770000660K
Deferred tax
0000000
Other non-current liabilities
67K150.40M150.46M149.82M183.99K32.18M0
Total non-current liabilities
67K150.40M150.46M149.82M183.99K32.18M660K
Total liabilities
25.96M160.12M156.21M151.30M4.38M34.02M1.48M
Data sourceData source